The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders
Open accessAbstract
Preeclampsia is a devastating medical complication of pregnancy that can lead to significant maternal and fetal morbidity and mortality. It is currently believed that there is abnormal placentation in as early as the first trimester in women destined to develop preeclampsia. Although the etiology of the abnormal placentation is being debated, numerous epidemiologic and experimental studies suggest that imbalances in circulating angiogenic factors released from the placenta are responsible for the maternal signs and symptoms of preeclampsia. In particular, circulating levels of soluble fms-like tyrosine kinase 1, an antiangiogenic factor, are markedly increased in women with preeclampsia, whereas free levels of its ligand, placental, growth factor are markedly diminished. Alterations in these angiogenic factors precede the onset of clinical signs of preeclampsia and correlate with disease severity. Recently, the availability of automated assays for the measurement of angiogenic biomarkers in the plasma, serum, and urine has helped investigators worldwide to demonstrate a key role for these factors in the clinical diagnosis and prediction of preeclampsia. Numerous studies have reported that circulating angiogenic biomarkers have a very high negative predictive value to rule out clinical disease among women with suspected preeclampsia. These blood-based biomarkers have provided a valuable tool to clinicians to accelerate the time to clinical diagnosis and minimize maternal adverse outcomes in women with preeclampsia. Angiogenic biomarkers have also been useful to elucidate the pathogenesis of related disorders of abnormal placentation such as intrauterine growth restriction, intrauterine fetal death, twin-to-twin transfusion syndrome, and fetal hydrops. In summary, the discovery and characterization of angiogenic proteins of placental origin have provided clinicians a noninvasive blood-based tool to monitor placental function and health and for early detection of disorders of placentation. Uncovering the mechanisms of altered angiogenic factors in preeclampsia and related disorders of placentation may provide insights into novel preventive and therapeutic options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–220 of 220
Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome
Wallace, K. L., Morris, R., Kyle, P. B., Cornelius, D. C., Darby, M. M., Scott, J., Moseley, J., Chatman, K., & LaMarca, B. B. (2013) · Hypertension in Pregnancy · doi:10.3109/10641955.2013.835820 · Cited by 40
Differential Diagnosis of Preeclampsia
Verdonk, K., Visser, W. E., Russcher, H., Danser, A. H. J., Steegers, E. A. P., & van den Meiracker, A. H. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.201459 · Cited by 38
Vogtmann, R., Kühnel, E., Dicke, N., Verkaik‐Schakel, R. N., Plösch, T., Schorle, H., Stojanovska, V., Herse, F., Köninger, A., Kimmig, R., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00165 · Cited by 38
Lou, W.-Z., Jiang, F., Hu, J., Chen, X., Song, Y., Zhou, X., Liu, J., Bian, X.-M., & Gao, J. (2019) · Disease Markers · doi:10.1155/2019/6270187 · Cited by 38
Ultrastructure of Uteroplacental Arteries
Wolf, F. D., Brosens, I. A., & Robertson, W. B. (1982) · Contributions to gynecology and obstetrics · doi:10.1159/000406847 · Cited by 38
Podjarny, E., Losonczy, G., & Baylis, C. (2004) · Seminars in Nephrology · doi:10.1016/s0270-9295(04)00131-7 · Cited by 37
Bell, M. J., Roberts, J. M., Founds, S. A., Jeyabalan, A., Terhorst, L. A., & Conley, Y. P. (2013) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-13-82 · Cited by 36
C-allele of rs4769613 Near FLT1 Represents a High-Confidence Placental Risk Factor for Preeclampsia
Kikas, T., Inno, R., Ratnik, K., Rull, K., & Laan, M. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15346 · Cited by 36
Yinon, Y., Ben-Meir, E., Berezowsky, A., Weisz, B., Schiff, E., Mazaki‐Tovi, S., & Lipitz, S. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.09.022 · Cited by 31
Mayer-Pickel, K. I., Kolovetsiou-Kreiner, V., Stern, C., Münzker, J., Eberhard, K., Trajanoski, S., Lakovschek, I.-C., Ulrich, D., Csapó, B., Lang, U., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091429 · Cited by 30
Placental expression of angiogenic factors in Trisomy 13
Silasi, M., Rana, S., Powe, C. E., Cohen, B., Lim, K.-H., Zsengellér, Z. K., Karumanchi, S. A., & Stillman, I. E. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.02.027 · Cited by 28
Self-citationChaiworapongsa, T., Romero, R. J., Kusanovic, J. P., Savasan, Z. A., Kim, S. K., Mazaki‐Tovi, S., Vaisbuch, E., Oggè, G., Madan, I., Dong, Z., et al. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050903443467 · Cited by 27
Govender, L., Mackraj, I., Gathiram, P., & Moodley, J. (2012) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2012-003 · Cited by 26
Shahul, S. S., Ramadan, H., Mueller, A., Nizamuddin, J., Nasim, R., Perdigao, J. L., Chinthala, S., Tung, A., & Rana, S. (2017) · Pregnancy Hypertension · doi:10.1016/j.preghy.2017.10.009 · Cited by 26
Self-citationOggè, G., Romero, R., Kusanovic, J. P., Chaiworapongsa, T., Dong, Z., Mittal, P., Vaisbuch, E., Mazaki-Tovi, S., Gonzalez, J. M., Yeo, L., et al. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050903366119 · Cited by 25 · cited 1×
“Furthermore, angiogenic factor thresholds for prospective studies should incorporate the matrix (serum vs plasma) before interpretation of the results, because significant differences have been reported for these factors in different matrices.(154)”
BackgroundFetal hydrops and the risk of severe preeclampsia
Burwick, R. M., Pilliod, R. A., Dukhovny, S. E., & Caughey, A. B. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1396312 · Cited by 20
Schmella, M. J., Assibey‐Mensah, V., Parks, W. T., Roberts, J. M., Jeyabalan, A., Hubel, C. A., & Catov, J. M. (2019) · Placenta · doi:10.1016/j.placenta.2019.02.014 · Cited by 19
Meeme, A., Buga, G., Mammen, M., & Namugowa, A. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1212832 · Cited by 18
Soluble fms-like tyrosine kinase-1 in HIV infected pre-eclamptic South African Black women
Govender, N., Moodley, J., Gathiram, P., & Naicker, T. (2014) · Placenta · doi:10.1016/j.placenta.2014.04.013 · Cited by 16
Evaluation of angiogenic factors in the decision to admit women with suspected preeclampsia
Suresh, S. C., Mueller, A., Salahuddin, S., Naseem, H., Dhir, R., & Rana, S. (2020) · Pregnancy Hypertension · doi:10.1016/j.preghy.2020.05.013 · Cited by 15
Self-citation
Cited by
Magee, L. A., Brown, M. A., Hall, D. R., Gupte, S., Hennessy, A., Karumanchi, S. A., Kenny, L. C., McCarthy, F., Myers, J., Poon, L. C., et al. (2022) · Pregnancy Hypertension · doi:10.1016/j.preghy.2021.09.008 · Cited by 1,134
Self-citationPreeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study
Papageorghiou, A. T., Deruelle, P., Gunier, R. B., Rauch, S., García-May, P. K., Mhatre, M., Usman, M. A., Abd-Elsalam, S., Etuk, S., Simmons, L. E., et al. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.05.014 · Cited by 311
“Outcomes The neonatal outcomes of interest were preterm birth (<37 weeks’ gestation), frequency of small for gestational age (SGA) neonates (birthweight below the 10th percentile for gestational age and sex according to the INTERGROWTH21 Newborn Size Standards),(22) and an unweighted index, namely the severe perinatal…”
BackgroundMethodInfluentialConde-Agudelo, A., & Romero, R. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.07.009 · Cited by 289
Preeclampsia and eclampsia: the conceptual evolution of a syndrome
Erez, O., Romero, R., Jung, E., Chaemsaithong, P., Bosco, M., Suksai, M., Gallo, D. M., & Gotsch, F. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.12.001 · Cited by 282
Hong, J., Crawford, K., Cavanagh, E., da Silva Costa, F., & Kumar, S. (2024) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.27513 · Cited by 21
“…factor (PlGF), a strongly proangiogenic hormone, and elevated levels of its antiangiogenic counterpart, soluble fms-like tyrosine kinase-1 (sFlt-1) 17,18 , as well as an increased sFlt-1/PlGF ratio are seen in women with pre-eclampsia and FGR, and are reflective of placental dysfunction 17,19–22 .”
Background
Metadata
- Authors
- Rana, S., Burke, S. D., & Karumanchi, S. A.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2022-02
- Volume
- 226
- Issue
- 2
- Pages
- S1019-S1034
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W3094227856
- Cited by
- 335
- References
- 220
- FWCI
- 18.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.